Inagaki, N., Yang, W., Watada, H., Ji, L., Schnaidt, S., Pfarr, E., . . . Nangaku, M. (2019). Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: Subgroup analysis of the randomized CARMELINA(®) trial. Diabetol Int.
Citação norma ChicagoInagaki, Nobuya, et al. "Linagliptin and Cardiorenal Outcomes in Asians With Type 2 Diabetes Mellitus and Established Cardiovascular And/or Kidney Disease: Subgroup Analysis of the Randomized CARMELINA(®) Trial." Diabetol Int 2019.
Citação norma MLAInagaki, Nobuya, et al. "Linagliptin and Cardiorenal Outcomes in Asians With Type 2 Diabetes Mellitus and Established Cardiovascular And/or Kidney Disease: Subgroup Analysis of the Randomized CARMELINA(®) Trial." Diabetol Int 2019.